FAM75A5 Inhibitors
FAM75A5 inhibitors are chemical compounds designed to diminish the functional activity of the FAM75A5 protein through indirect mechanisms, given that direct inhibitors are not well-characterized. These inhibitors interact with various signaling pathways and cellular processes that are potentially linked to the regulatory functions of FAM75A5. Kinase inhibitors, for example, disrupt the activity of multiple kinases which could affect the phosphorylation state of proteins, thereby modulating the activity of FAM75A5 if it is involved in such signaling cascades. By targeting key molecules in pathways like mTOR, PI3K/Akt, and MAPK/ERK, which govern cell growth, proliferation, and survival, these inhibitors can lead to the downregulation of FAM75A5 activity if it is a component or a downstream effector of these pathways.
The inhibition spectrum also extends to other cellular pathways potentially linked to FAM75A5's role within the cell. For instance, inhibitors of the JNK signaling pathway, which is implicated in apoptosis and cell differentiation, could indirectly reduce FAM75A5 activity if it is associated with these processes. Inhibitors of the Hedgehog signaling pathway and ROCK, which are involved in developmental processes and actin cytoskeleton dynamics respectively, may also impact FAM75A5 function if it is connected to these cellular functions. Furthermore, agents that modify proteasome activity or chromatin structure, like proteasome inhibitors and histone deacetylase inhibitors, could impact the stability and expression of FAM75A5.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Staurosporine | 62996-74-1 | sc-3510 sc-3510A sc-3510B | 100 µg 1 mg 5 mg | $82.00 $153.00 $396.00 | 113 | |
A potent kinase inhibitor that targets multiple kinases which might be regulating FAM75A5 phosphorylation status. Inhibition of these kinases could result in decreased phosphorylation of FAM75A5, leading to reduced functional activity. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
A phosphoinositide 3-kinases (PI3K) inhibitor that would disrupt PI3K/AKT pathway signaling. Since PI3K can regulate various proteins including FAM75A5, inhibition by LY 294002 could lead to reduced activity of FAM75A5 by preventing its PI3K-mediated activation. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
A PI3K inhibitor that prevents the activation of the PI3K/AKT pathway. Wortmannin would lead to decreased activity of FAM75A5 by blocking its PI3K/AKT-mediated regulation. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
An mTOR inhibitor which could downregulate the mTOR signaling pathway, a pathway that might be involved in the regulation of FAM75A5. By inhibiting mTOR, Rapamycin could indirectly inhibit the activity of FAM75A5. | ||||||
U-0126 | 109511-58-2 | sc-222395 sc-222395A | 1 mg 5 mg | $64.00 $246.00 | 136 | |
An inhibitor of MEK1/2, which are upstream regulators of the ERK pathway. By inhibiting MEK1/2, U0126 could prevent the activation of downstream targets and potentially reduce the regulatory influence on FAM75A5, leading to its functional inhibition. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
A p38 MAPK inhibitor that would prevent the activation of p38 MAPK signaling. Since p38 MAPK can influence various cellular processes, inhibiting this kinase could lead to a decrease in FAM75A5 activity if it is regulated by p38 MAPK. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
A specific inhibitor of MEK, which would block the activation of the MAPK/ERK pathway. Inhibition of this pathway could reduce the activity of FAM75A5 if it is under the control of MAPK/ERK signaling. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
An inhibitor of JNK, which could decrease the activity of FAM75A5 assuming it is regulated by JNK signaling. By inhibiting JNK, SP600125 could lead to a reduction in FAM75A5 functional activity. | ||||||
Bortezomib | 179324-69-7 | sc-217785 sc-217785A | 2.5 mg 25 mg | $135.00 $1085.00 | 115 | |
A proteasome inhibitor that could lead to the accumulation of misfolded proteins, potentially affecting protein homeostasis and indirectly leading to decreased activity of FAM75A5 if it relies on proteostatic mechanisms for its function. | ||||||
Cyclosporin A | 59865-13-3 | sc-3503 sc-3503-CW sc-3503A sc-3503B sc-3503C sc-3503D | 100 mg 100 mg 500 mg 10 g 25 g 100 g | $63.00 $92.00 $250.00 $485.00 $1035.00 $2141.00 | 69 | |
Inhibits calcineurin, thereby preventing the dephosphorylation and nuclear translocation of NFAT transcription factors. If FAM75A5 is regulated by NFAT, inhibition by Cyclosporine A could reduce its activity. | ||||||